The article you requested is
CAD-MDD: Not Diagnostic, Lacks Screening Data
J Clin Psychiatry 2014;75(1):85 [letter]
Copyright 2014 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
- Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: In the recent article by Gibbons and colleagues, their Computerized Adaptive Diagnostic Test for Major Depressive Disorder (CAD-MDD) was presented as a “diagnostic screening tool.” However, the authors themselves stated, “Screening measures, like the CAD-MDD, are not diagnostic measures….” Consistency is needed. The term diagnostic screening tool is self-contradictory, and calling this test “diagnostic” is misleading. Screening tests do not make diagnoses—they assess the likelihood of undeclared disease.